$0.00
(+0.00%
) Quote details
USD
+$0.00
(+0.00%
)At Close (As of Nov 26, 2025)
$4.20B
Market Cap
15.7
P/E Ratio
1.58
EPS
$26.65
52 Week High
$13.40
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
ACADIA Pharmaceuticals Inc. is a leading biopharmaceutical company headquartered in San Diego, California, focused on developing and commercializing innovative therapies for central nervous system disorders. The company has established a strong pipeline of small molecule drugs aimed at addressing critical unmet medical needs, especially in treating Parkinson's disease psychosis and schizophrenia. ACADIA's dedication to scientific innovation, supported by strategic partnerships, enhances its position within the competitive healthcare landscape, targeting improved patient outcomes while fostering sustainable growth in the biopharmaceutical industry.
LPTX
NVDA
VHAI
BYND
KTTA
ZYXI
AMBR
BITF
PLUG
NIO
IPG
ASST
CLSK
AAL
TSLA
CIFR
SOFI
INTC
GOOGL
ADAP
MARA
WULF
HOOD
KVUE
F
AMD
SNDK
WBD
DNN
TLRY
BTBT
GRAB
RIG
PLTR
PFE
HBAN
IVP
AGNC
BAC
CCL
SNAP
GOOG
RGTI
AVGO
VALE
NFLX
MTSR
PLTD
T
IREN
ORCL
NTNX
MSFT
ITUB
DVLT
PCG
NOK
CMG
HBI
CAN
HPQ
APLD
LPTX
NVDA
VHAI
BYND
KTTA
ZYXI
AMBR
BITF
PLUG
NIO
IPG
ASST
CLSK
AAL
TSLA
CIFR
SOFI
INTC
GOOGL
ADAP
MARA
WULF
HOOD
KVUE
F
AMD
SNDK
WBD
DNN
TLRY
BTBT
GRAB
RIG
PLTR
PFE
HBAN
IVP
AGNC
BAC
CCL
SNAP
GOOG
RGTI
AVGO
VALE
NFLX
MTSR
PLTD
T
IREN
ORCL
NTNX
MSFT
ITUB
DVLT
PCG
NOK
CMG
HBI
CAN
HPQ
APLD